Annual EBIT
-$278.75 M
-$19.90 M-7.69%
31 December 2023
Summary:
CureVac NV annual earnings before interest & taxes is currently -$278.75 million, with the most recent change of -$19.90 million (-7.69%) on 31 December 2023. During the last 3 years, it has fallen by -$155.70 million (-126.53%). CVAC annual EBIT is now -233.16% below its all-time high of -$79.20 million.CVAC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$407.71 M
+$484.26 M+632.65%
01 September 2024
Summary:
CureVac NV quarterly earnings before interest & taxes is currently $407.71 million, with the most recent change of +$484.26 million (+632.65%) on 01 September 2024. Over the past year, it has increased by +$460.06 million (+878.89%). CVAC quarterly EBIT is now at all-time high.CVAC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$164.44 M
+$460.06 M+155.63%
01 September 2024
Summary:
CureVac NV TTM earnings before interest & taxes is currently $164.44 million, with the most recent change of +$460.06 million (+155.63%) on 01 September 2024. Over the past year, it has increased by +$479.98 million (+152.12%). CVAC TTM EBIT is now at all-time high.CVAC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CVAC EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.7% | +878.9% | +152.1% |
| 3 y3 years | -126.5% | +344.3% | +130.7% |
| 5 y5 years | -233.2% | +2168.9% | +476.8% |
CVAC EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -126.5% | +41.4% | at high | +344.3% | at high | +130.7% |
| 5 y | 5 years | -233.2% | +41.4% | at high | +329.4% | at high | +130.7% |
| alltime | all time | -233.2% | +41.4% | at high | +329.4% | at high | +130.7% |
CureVac NV EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $407.71 M(-632.7%) | $164.44 M(-155.6%) |
| June 2024 | - | -$76.54 M(+1.3%) | -$295.62 M(+1.7%) |
| Mar 2024 | - | -$75.54 M(-17.2%) | -$290.61 M(+5.4%) |
| Dec 2023 | -$278.75 M(+7.7%) | -$91.19 M(+74.2%) | -$275.72 M(-12.6%) |
| Sept 2023 | - | -$52.35 M(-26.8%) | -$315.54 M(+1.6%) |
| June 2023 | - | -$71.54 M(+18.0%) | -$310.64 M(+3.6%) |
| Mar 2023 | - | -$60.65 M(-53.7%) | -$299.79 M(+18.0%) |
| Dec 2022 | -$258.85 M(-45.6%) | -$131.01 M(+176.1%) | -$254.01 M(+98.7%) |
| Sept 2022 | - | -$47.45 M(-21.8%) | -$127.85 M(-48.3%) |
| June 2022 | - | -$60.69 M(+308.3%) | -$247.31 M(-32.1%) |
| Mar 2022 | - | -$14.86 M(+206.8%) | -$364.36 M(-24.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$475.83 M(+286.7%) | -$4.84 M(-97.1%) | -$480.70 M(-10.2%) |
| Sept 2021 | - | -$166.91 M(-6.1%) | -$535.08 M(+31.6%) |
| June 2021 | - | -$177.74 M(+35.5%) | -$406.63 M(+75.1%) |
| Mar 2021 | - | -$131.20 M(+121.5%) | -$232.20 M(+85.1%) |
| Dec 2020 | -$123.05 M(+11.4%) | -$59.23 M(+54.0%) | -$125.47 M(+16.6%) |
| Sept 2020 | - | -$38.46 M(+1059.3%) | -$107.63 M(+21.1%) |
| June 2020 | - | -$3.32 M(-86.4%) | -$88.88 M(+3.9%) |
| Mar 2020 | - | -$24.47 M(-40.9%) | -$85.56 M(+0.6%) |
| Dec 2019 | -$110.46 M(+32.0%) | -$41.38 M(+110.0%) | -$85.03 M(+94.8%) |
| Sept 2019 | - | -$19.71 M(-17.7%) | -$43.65 M(+82.3%) |
| Mar 2019 | - | -$23.94 M | -$23.94 M |
| Dec 2018 | -$83.67 M | - | - |
FAQ
- What is CureVac NV annual earnings before interest & taxes?
- What is the all time high annual EBIT for CureVac NV?
- What is CureVac NV annual EBIT year-on-year change?
- What is CureVac NV quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for CureVac NV?
- What is CureVac NV quarterly EBIT year-on-year change?
- What is CureVac NV TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for CureVac NV?
- What is CureVac NV TTM EBIT year-on-year change?
What is CureVac NV annual earnings before interest & taxes?
The current annual EBIT of CVAC is -$278.75 M
What is the all time high annual EBIT for CureVac NV?
CureVac NV all-time high annual earnings before interest & taxes is -$79.20 M
What is CureVac NV annual EBIT year-on-year change?
Over the past year, CVAC annual earnings before interest & taxes has changed by -$19.90 M (-7.69%)
What is CureVac NV quarterly earnings before interest & taxes?
The current quarterly EBIT of CVAC is $407.71 M
What is the all time high quarterly EBIT for CureVac NV?
CureVac NV all-time high quarterly earnings before interest & taxes is $407.71 M
What is CureVac NV quarterly EBIT year-on-year change?
Over the past year, CVAC quarterly earnings before interest & taxes has changed by +$460.06 M (+878.89%)
What is CureVac NV TTM earnings before interest & taxes?
The current TTM EBIT of CVAC is $164.44 M
What is the all time high TTM EBIT for CureVac NV?
CureVac NV all-time high TTM earnings before interest & taxes is $164.44 M
What is CureVac NV TTM EBIT year-on-year change?
Over the past year, CVAC TTM earnings before interest & taxes has changed by +$479.98 M (+152.12%)